Mosconi L, Mistur R, Switalski R, Tsui WHon, Glodzik L, Li Y, Pirraglia E, de Santi S, Reisberg B, Wisniewski T et al..  2009.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 36(5):811-22.

Brys M, Glodzik L, Mosconi L, Switalski R, de Santi S, Pirraglia E, Rich K, Kim BC, Mehta P, Zinkowski R et al..  2009.  Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.. J Alzheimers Dis. 16(2):351-62.

Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, de Santi S, Zinkowski R, Mehta P et al..  2009.  Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.. Neurobiol Aging. 30(5):682-90.

Kamer AR, Craig RG, Pirraglia E, Dasanayake AP, Norman RG, Boylan RJ, Nehorayoff A, Glodzik L, Brys M, de Leon MJ.  2009.  TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.. J Neuroimmunol. 216(1-2):92-7.

Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ.  2008.  Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis.. J Alzheimers Dis. 13(4):437-49.

King KG, Glodzik L, Liu S, Babb JS, de Leon MJ, Gonen O.  2008.  Anteroposterior hippocampal metabolic heterogeneity: three-dimensional multivoxel proton 1H MR spectroscopic imaging--initial findings.. Radiology. 249(1):242-50.

Mosconi L, Pupi A, de Leon MJ.  2008.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.. Ann N Y Acad Sci. 1147:180-95.

Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH.  2008.  Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.. Biol Psychiatry. 64(10):871-9.

Mosconi L, de Santi S, Li J, Tsui WHon, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ.  2008.  Hippocampal hypometabolism predicts cognitive decline from normal aging.. Neurobiol Aging. 29(5):676-92.

Mosconi L, de Santi S, Brys M, Tsui WH, Pirraglia E, Glodzik-Sobanska L, Rich KE, Switalski R, Mehta PD, Pratico D et al..  2008.  Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.. Biol Psychiatry. 63(6):609-18.

Kamer AR, Craig RG, Dasanayake AP, Brys M, Glodzik-Sobanska L, de Leon MJ.  2008.  Inflammation and Alzheimer's disease: possible role of periodontal diseases.. Alzheimers Dement. 4(4):242-50.

Glodzik L, King KG, Gonen O, Liu S, de Santi S, de Leon MJ.  2008.  Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study.. Prog Neuropsychopharmacol Biol Psychiatry. 32(4):1005-12.

Reisberg B, Ferris SH, Kluger A, Franssen E, Wegiel J, de Leon MJ.  2008.  Mild cognitive impairment (MCI): a historical perspective.. Int Psychogeriatr. 20(1):18-31.

Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S et al..  2008.  Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.. J Nucl Med. 49(3):390-8.

Sigurdsson EM, Wadghiri YZ, Mosconi L, Blind JA, Knudsen E, Asuni A, Scholtzova H, Tsui WH, Li Y, Sadowski M et al..  2008.  A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.. Neurobiol Aging. 29(6):836-47.

Reisberg B, Prichep L, Mosconi L, E John R, Glodzik-Sobanska L, Boksay I, Monteiro I, Torossian C, Vedvyas A, Ashraf N et al..  2008.  The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease.. Alzheimers Dement. 4(1 Suppl 1):S98-S108.

Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Någren K, Kim B-C, Tsui W et al..  2008.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 35(12):2169-81.

de Santi S, Pirraglia E, Barr W, Babb J, Williams S, Rogers K, Glodzik L, Brys M, Mosconi L, Reisberg B et al..  2008.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.. Neuropsychology. 22(4):469-84.

Mosconi L, Tsui WHon, Pupi A, de Santi S, Drzezga A, Minoshima S, de Leon MJ.  2007.  (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.. J Nucl Med. 48(7):1129-34.

Mosconi L, Brys M, Glodzik-Sobanska L, de Santi S, Rusinek H, de Leon MJ.  2007.  Early detection of Alzheimer's disease using neuroimaging.. Exp Gerontol. 42(1-2):129-38.

Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, de Santi S, de Leon MJ.  2007.  Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.. Proc Natl Acad Sci U S A. 104(48):19067-72.

Mosconi L, Tsui WH, Rusinek H, de Santi S, Li Y, Wang G-J, Pupi A, Fowler J, de Leon MJ.  2007.  Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 34(9):1467-79.

de Leon MJ, Mosconi L, Logan J.  2007.  Seeing what Alzheimer saw.. Nat Med. 13(2):129-31.

Glodzik-Sobanska L, Reisberg B, de Santi S, Babb JS, Pirraglia E, Rich KE, Brys M, de Leon MJ.  2007.  Subjective memory complaints: presence, severity and future outcome in normal older subjects.. Dement Geriatr Cogn Disord. 24(3):177-84.

Blennow K, de Leon MJ, Zetterberg H.  2006.  Alzheimer's disease.. Lancet. 368(9533):387-403.